missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ NDUFB9 Polyclonal Antibody
Description
A suggested positive control is human liver tissue lysate. PA5-20922 can be used with blocking peptide PEP-1036.
LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
Specifications
Specifications
| Antigen | NDUFB9 |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | Ndufb9 |
| Gene Accession No. | Q9CQJ8, Q9Y6M9 |
| Gene Alias | 1190008J14Rik; B22; CI-B22; complex I B22 subunit; complex I-B22; EGK_19260; LYR motif-containing protein 3; LYRM3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9; NADH:ubiquinone oxidoreductase subunit B9; NADH-ubiquinone oxidoreductase B22 subunit; NDUFB9; UQOR22 |
| Gene Symbols | Ndufb9 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?